Tumour-endothelium interactions in co-culture: Coordinated changes of gene expression profiles and phenotypic properties of endothelial cells

Journal of Cell Science

Volumn 116, Issue 6, 2003, Pages 1013-1022

  Khodarev, Nikolai N ^a   Yu, Jianqing ^a   Labay, Edwardine ^a   Darga, Thomas ^a   Brown, Charles K ^a   Mauceri, Helena J ^a   Yassari, Reza ^a   Gupta, Nalin ^b   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Autocrine loops; Expressional profiling; Intercellular communication and activation

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; COMPLEMENTARY DNA; CYSTEINE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; LIGAND; RANTES; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3;

ANGIOGENESIS; AUTOCRINE EFFECT; CELL ACTIVATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENOTYPE; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; TUMOR CELL; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; AUTOCRINE COMMUNICATION; CELL COMMUNICATION; CELL MOVEMENT; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GLIOMA; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PHENOTYPE; PLASMINOGEN; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; RECEPTORS, CYTOKINE; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0037444476     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00281     Document Type: Review

References (45)

1. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
2. Ausprunk, D. H. and Folkman, J. (1977). Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc. Res. 14, 53-65.
3. Belloni, A. S., Albertin, G., Forneris, M. L. and Nussdorfer, G. G. (2001). Proadrenomedullin-derived peptides as autocrine-paracrine regulators of cell growth. Histol. Histopathol. 16, 1263-1274.
4. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
5. Darland, D. C. and D'Amore, P. A. (1999). Blood vessel maturation: vascular development comes of age. J. Clin. Invest. 103, 157-158.
6. de Waard, V., van den Berg, B. M., Veken, J., Schultz-Heienbrok, R., Pannekoek, H. and van Zonneveld, A. J. (1999). Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus. Gene 226, 1-8.
7. Dell'Era, P., Belleri, M., Stabile, H., Massardi, M. L., Ribatti, D. and Presta, M. (2001). Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. Oncogene 20, 2655-2663.
8. Denekamp, J. (1993). Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 66, 181-196.
9. Denekamp, J. and Hill, S. (1991). Angiogenic attack as a therapeutic strategy for cancer. Radiother. Oncol. 20, 103-112.
10. Eisen, M. B., Spellman, P. T., Brown, P. O. and Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
11. Fidler, I. J. and Ellis, L. M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
12. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
13. Folkman, J. and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
14. Freeman, W. M., Robertson, D. J. and Vrana, K. E. (2000). Fundamentals of DNA hybridization arrays for gene expression analysis. Biotechniques 29, 1042-1046, 1048-1055.
15. Freyer, D., Manz, R., Ziegenhorn, A., Weih, M., Angstwurm, K., Docke, W. D., Meisel, A., Schumann, R. R., Schonfelder, G., Dirnagl, U. et al. (1999). Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J. Immunol. 163, 4308-4314.
16. Gastl, G., Hermann, T., Steurer, M., Zmija, J., Gunsilius, E., Unger, C. and Kraft, A. (1997). Angiogenesis as a target for tumour treatment. Oncology 54, 177-184.
17. Girard, J. P., Baekkevold, E. S., Yamanaka, T., Haraldsen, G., Brandtzaeg, P. and Amalric, F. (1999). Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am. J. Pathol. 155, 2043-2055.
18. Glienke, J., Schmitt, A. O., Pilarsky, C., Hinzmann, B., Weiss, B., Rosenthal, A. and Thierauch, K. H. (2000). Differential gene expression by endothelial cells in distinct angiogenic states. Eur. J. Biochem. 267, 2820-2830.
19. Hanahan, D. (1988). Dissecting multistep tumourigenesis in transgenic mice. Annu Rev Genet 22, 479-519.
20. Hanahan, D., Christofori, G., Naik, P. and Arbeit, J. (1996). Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls and prospects for preclinical therapeutic models. Eur. J. Cancer 32A, 2386-2393.
21. Hanahan, D. and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86, 353-364.
22. Iyer, V. R., Eisen, M. B., Ross, D. T., Schuler, G., Moore, T., Lee, J. C., Trent, J. M., Staudt, L. M., Hudson, J., Jr, Boguski, M. S. et al. (1999). The transcriptional program in the response of human fibroblasts to serum. Science 283, 83-87.
23. Kahn, J., Mehraban, F., Ingle, G., Xin, X., Bryant, J. E., Vehar, G., Schoenfeld, J., Grimaldi, C. J., Peale, F., Draksharapu, A. et al. (2000). Gene expression profiling in an in vitro model of angiogenesis. Am. J. Pathol. 156, 1887-1900.
24. Kerbel, R. S. (1991). Inhibition of tumour angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssays 13, 31-36.
25. Khodarev, N. N., Advani, S. J., Gupta, N., Roizman, B. and Weichselbaum, R. R. (1999). Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96, 12062-12067.
26. Khodarev, N. N., Park, J. O., Yu, J., Gupta, N., Nodzenski, E., Roizman, B. and Weichselbaum, R. R. (2001). Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumour cells and tumour xenografts. Proc. Natl. Acad. Sci. USA 98, 12665-12670.
27. Khodarev, N. N., Yu, J., Nodzenski, E., Murley, J. S., Kataoka, Y., Brown, C. K., Grdina, D. J. and Weichselbaum, R. R. (2002). Method of RNA purification from endothelial cells for DNA array experiments. Biotechniques 32, 316-318.
28. Lal, A., Lash, A. E., Altschul, S. F., Velculescu, V., Zhang, L., McLendon, R. E., Marra, M. A., Prange, C., Morin, P. J., Polyak, K. et al. (1999). A public database for gene expression in human cancers. Cancer Res. 59, 5403-5407.
29. Lin, Y., Weisdorf, D. J., Solovey, A. and Hebbel, R. P. (2000). Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71-77.
30. Nikitenko, L. L., MacKenzie, I. Z., Rees, M. C. and Bicknell, R. (2000). Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol. Hum. Reprod. 6, 811-819.
31. Nicosia, R. F., Tchao, R. and Leighton, J. (1982). Hystotipic angiogenesis in vitro: light microscopic, ultrastructural and radioautographic studies. In vitro 18, 538-549.
32. O'Reilly, M. (1997). Angiostatin: an endogenous inhibitor of angiogenesis and of tumour growth. Exs 79, 273-294.
33. O'Reilly, M., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell 88, 277-285.
34. Paweletz, N. and Knierim, M. (1989). Tumour-related angiogenesis. Crit. Rev. Oncol. Hematol. 9, 197-242.
35. Pepe, M. S. (2000). An interpretation for the ROC curve and inference using GLM procedures. Biometrics 56, 352-359.
36. Poole, L. J., Yu, Y., Kim, P. S., Zheng, Q. Z., Pevsner, J. and Hayward, G. S. (2002). Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus. J. Virol. 76, 3395-3420.
37. Potts, J. D., Dagle, J. M., Walder, J. A., Weeks, D. L. and Runyan, R. B. (1991). Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc. Natl. Acad. Sci. USA 88, 1516-1520.
38. Rak, J. W., St Croix, B. D. and Kerbel, R. S. (1995). Consequences of angiogenesis for tumour progression, metastasis and cancer therapy. Anticancer Drugs 6, 3-18.
39. Ruoslahti, E. and Rajotte, D. (2000). An address system in the vasculature of normal tissues and tumours. Annu. Rev. Immunol. 18, 813-827.
40. St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B. et al. (2000). Genes expressed in human tumour endothelium. Science 289, 1197-1202.
41. Stanton, L. W., Garrard, L. J., Damm, D., Garrick, B. L., Lam, A., Kapoun, A. M., Zheng, Q., Protter, A. A., Schreiner, G. F. and White, R. T. (2000). Altered patterns of gene expression in response to myocardial infarction. Circ. Res. 86, 939-945.
42. Tada, M., Diserens, A. C., Desbailets, I. and de Tribolet, N. (1994). Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J. Neurosurg. 80, 1063-1073.
43. Watson, M. A., Perry, A., Budhjara, V., Hicks, C., Shannon, W. D. and Rich, K. M. (2001). Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas. Cancer Res. 61, 1825-1829.
44. Westphal, M., Meima, L., Szonyi, E., Lofgren, J., Meissner, H., Hamel, W., Nikolics, K. and Sliwkowski, M. X. (1997). Heregulins and the ErbB-2/3/4 receptors in gliomas. J. Neurooncol. 35, 335-346.
45. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.